S-roscovitine-a potential neuroprotectant for stroke

Nature Reviews Neurology

Volumn 6, Issue 10, 2010, Pages 527-

  Wood, Heather ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; NEUROPROTECTIVE AGENT; ROSCOVITINE;

ANIMAL MODEL; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; DRUG DELIVERY SYSTEM; DRUG TARGETING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 77957897285     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.135     Document Type: Short Survey

References (1)

1. Original article Menn, B. et al. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS ONES, e12117 (2010)